TAB3 Activators are a diverse group of chemical compounds that indirectly enhance the functional activity of TAB3, primarily through their interactions with the NF-κB signaling pathway. Resveratrol and Curcumin both influence TAB3 activity by modulating the NF-κB pathway; Resveratrol does so through SIRT1 activation leading to deacetylation of NF-κB components, while Curcumin inhibits the pathway upstream, affecting TAB3's role in NF-κB signaling. DL-Sulforaphane and (-)-Epigallocatechin Gallate also contribute to this modulation, with DL-Sulforaphane targeting the Nrf2 pathway, thereby intersecting with NF-κB signaling, and (-)-Epigallocatechin Gallate inhibiting key kinases within the NF-κB pathway. Piperlongumine and Kaempferol indirectly activate TAB3 by affecting oxidative stress pathways and the MAPK pathways, respectively, both of which have significant interactions with NF-κB signaling. This series of interactions underscores the complex network of pathways influencing TAB3 activity, with each compound contributing to the enhancement of TAB3's function within this intricate signaling web.
Further adding to this complex interaction are compounds like Quercetin, Parthenolide, and Anacardic acid. Quercetin modulates the PI3K/Akt pathway, another crucial intersecting point with NF-κB signaling, thereby influencing TAB3 activity. Parthenolide acts by inhibiting NF-κB signaling upstream, leading to a compensatory increase in TAB3 activity. Anacardic acid's inhibition of histone acetyltransferases also impacts NF-κB signaling, thus enhancing TAB3 activity. Additionally, Isoliquiritigenin, Xanthohumol from hop (Humulus lupulus), and Genistein each contribute to the regulation of TAB3 through their respective modulation of MAPK pathways, multiple signaling pathways including NF-κB, and inhibition of tyrosine kinases. These compounds, through their targeted effects on various signaling pathways, collectively facilitate the enhancement of TAB3-mediated functions, highlighting the role of TAB3 as a central player in the dynamic and interconnected signaling pathways within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol enhances TAB3 activity by activating SIRT1, which is known to modulate NF-κB signaling. Activation of SIRT1 leads to deacetylation of components in the NF-κB pathway, indirectly enhancing TAB3's role in this signaling cascade. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin indirectly activates TAB3 by inhibiting the NF-κB pathway. It modulates various components upstream of NF-κB, leading to altered TAB3 activity as TAB3 is a key adaptor in NF-κB signaling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
DL-Sulforaphane enhances TAB3 activity by modulating the Nrf2 pathway, which intersects with NF-κB signaling. Nrf2 activation can lead to changes in oxidative stress responses, indirectly influencing TAB3's role in NF-κB signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
(-)-Epigallocatechin Gallate enhances TAB3 activity by inhibiting NF-κB signaling. By modulating key kinases in this pathway, (-)-Epigallocatechin Gallate indirectly increases TAB3 activity, as TAB3 is involved in the NF-κB signaling cascade. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Piperlongumine activates TAB3 by modulating oxidative stress pathways. This leads to alterations in NF-κB signaling, indirectly enhancing TAB3's activity due to its role in this pathway. | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $97.00 $212.00 $500.00 | 11 | |
Kaempferol enhances TAB3 activity by influencing MAPK pathways, which are linked to NF-κB signaling. This modulation can indirectly lead to increased TAB3 activity in the NF-κB pathway. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin indirectly activates TAB3 by modulating the PI3K/Akt pathway, which intersects with NF-κB signaling. This leads to altered TAB3 activity, as it plays a critical role in NF-κB signaling. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide enhances TAB3 activity by inhibiting NF-κB signaling. It acts upstream in the pathway, leading to compensatory mechanisms that increase the activity of TAB3 within this pathway. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic acid activates TAB3 indirectly by inhibiting histone acetyltransferases, which affects NF-κB signaling. This inhibition can lead to increased TAB3 activity within the NF-κB pathway. | ||||||
Isoliquiritigenin | 961-29-5 | sc-255222 | 10 mg | $310.00 | 1 | |
Isoliquiritigenin enhances TAB3 activity by modulating the MAPK pathway. This influences NF-κB signaling, indirectly leading to increased TAB3 activity due to its role in this pathway. | ||||||